Company Overview
About Labviva
Labviva is a Boston-based life sciences technology company founded in 2017 by Lina Nilsson and Barry Bettman. It operates a digital procurement marketplace purpose-built for scientific researchers at pharmaceutical companies, biotech firms, academic research institutions, and hospitals. The platform aggregates product catalogs from thousands of scientific suppliers — including reagents, lab equipment, consumables, and biological materials — into a unified, searchable interface that integrates directly with institutional procurement and ERP systems such as SAP, Coupa, and Jaggaer. This eliminates the fragmented, email-and-catalog-driven purchasing workflows that dominate scientific procurement.
Business Model & Competitive Advantage
The company raised a $22M Series A in 2022 led by Ulu Ventures and MassMutual Ventures. Labviva's marketplace enables procurement teams and researchers to compare products, manage compliance requirements (such as controlled substance tracking and hazardous material handling), track orders across suppliers, and access data-driven insights on purchasing patterns. By integrating with institutional e-procurement systems, Labviva positions itself as an enterprise-grade overlay on top of existing procurement infrastructure rather than a standalone shopping portal — driving faster user adoption in large institutions.
Competitive Landscape 2025–2026
Labviva differentiates in the scientific procurement market — which includes competitors like Quartzy, Biocompare, and direct supplier portals — through its deep ERP integration capability, its compliance-aware purchasing workflows, and its supplier-side analytics tools that give scientific suppliers visibility into buying patterns and competitive positioning. The platform addresses a specialized need: science procurement involves highly technical product specifications, lot traceability requirements, and regulatory constraints that general B2B procurement tools handle poorly.
Frequently Asked Questions
Similar Brands
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, acti
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Compare Labviva with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Labviva? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Labviva Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Labviva vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →